questionText: To ask the Secretary of State for Health and Social Care, by what date liquid biopsy technologies will be routinely available for brain tumour patients across the NHS; how many additional patients are expected to gain access to targeted or repurposed treatments as a result; what barriers currently prevent access to such treatments where the same mutation is already treated in another cancer type; and who will be responsible for working to remove those barriers.